| COVID-19 |
1 |
1 |
| Genomic Medicine |
0 |
0.99 |
| Stem Cell Research and Therapy |
0 |
0.64 |
| Bone Marrow |
0 |
0.61 |
| Bone |
0 |
0.43 |
| Epigenetics |
0 |
0.43 |
| Blood |
0 |
0.29 |
| Critical Illness |
0 |
0.29 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.29 |
| Leukemia |
0 |
0.25 |
| Influenza |
0 |
0.2 |
| Allergy |
0 |
0.14 |
| Autoimmune Disease |
0 |
0.14 |
| Cancer |
0 |
0.14 |
| Cytokines |
0 |
0.14 |
| Diversity |
0 |
0.14 |
| Genetics |
0 |
0.14 |
| Immunization |
0 |
0.14 |
| Lung |
0 |
0.14 |
| New York |
0 |
0.14 |
| Pandemic |
0 |
0.14 |
| Social Determinants of Health |
0 |
0.13 |